Atlas Trials

Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

Clinical trial NCT05571592 · COMPLETED

Trial details

NCT number
NCT05571592
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Social Anxiety Disorder
Start date
2023-01-26
Primary completion
2025-11-26
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.